Skip to content
Wednesday, April 29, 2026
  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
  • Home
  • 2023
  • April
  • 26
  • US FDA approves Seres Therapeutics’ pill for deadly C. difficile infections
  • FILE PHOTO: FILE PHOTO: Signage is seen outside of FDA

    FILE PHOTO: FILE PHOTO: Signage is seen outside of FDA

    FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly

    Post navigation

    Previous: US FDA approves Seres Therapeutics’ pill for deadly C. difficile infections

    Live Market Pulse

    The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

    Sign up for our free The Cheap Investor Newsletter!

    Discover new market trends and ideas directly to your inbox.

    ✅ You're in! Check your inbox soon.

    By submitting your email address, you'll receive a free subscription to The Cheap Investor newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.

    Recent Posts

    • Kinross Tonight: The Cash Flow Tell
    • Kinross Tonight: The Cash Flow Tell
    • What Meta’s Earnings Report Won’t Tell You Tonight
    • Walmart opens third U.S. milk processing facility with $350 million investment
    • The OpenAI Reality Check: When one growth miss hits the whole AI chain
    • SpaceX Wants $1.75 Trillion.
    • US Supreme Court hears Bayer’s fight against Roundup lawsuits
    • The $5 Trillion Question: Is Nvidia Still a Buy?

    Categories

    • Headlines
    • Business
    • Economy
    • Politics
    • Top News
    • Newsletters

    • Home
    • Disclaimer
    • Contact Us
    • Terms of Service
    • Privacy Policy
    Copyright 2026 © All rights reserved | The Cheap Investor | thecheapinvestor.com
    SITE_OK